(Q47818989)

5 February 2018

review article

1 reference

title

Psychoneuroendocrinology of schizophrenia (English)

1 reference

5 February 2018

0 references

Marx CE

1

1 reference

5 February 2018

Lieberman JA

series ordinal

2

1 reference

5 February 2018

publication date

1 June 1998

1 reference

5 February 2018

Psychiatric Clinics of North America

published in

1 reference

5 February 2018

volume

21

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

413-434

1 reference

5 February 2018

Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender differences in schizophrenia: rehospitalization and community survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Neuroprotection against oxidative stress by estrogens: structure-activity relationship

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The modulation of brain dopamine and GABAA receptors by estradiol: a clue for CNS changes occurring at menopause.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Noradrenergic and dopaminergic interrelation in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The gonadal axis in men with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Longitudinal growth hormone studies in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender differences in schizophrenia: hormonal effect or subtypes?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The neurodevelopmental basis of sex differences in schizophrenia1

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Sex and Schizophrenia: Effects of Diagnostic Stringency, and Associations with Premorbid Variables

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Circadian and Sleep-Related Endocrine Rhythms in Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Adrenergic receptor sensitivity in depression. Effects of clonidine in depressed patients and healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The GH response to clonidine in endogenous as compared with reactive depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone and other responses to clonidine in patients with endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Sex differences in neuroanatomical and clinical correlations in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Impact of childbirth on a series of schizophrenic mothers: a comment on the possible influence of oestrogen on schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Polydipsia and water intoxication in psychiatric patients: a review of the epidemiological literature

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Modulation of brain dopamine transmission by sex steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effects of estrogens on the characteristics of [3H]spiroperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effect of chronic estradiol treatment on dopamine concentrations in discrete brain nuclei of hypophysectomized female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effect of prolactin and estradiol on rat striatal dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

In vitro progesterone modulates amphetamine-stimulated dopamine release from the corpus striatum of castrated male rats treated with estrogen.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of ovariectomized rats

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender differences in age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effects of Catechol Estrogens1and Catecholamines on Hypothalamic and Corpus Striatal Tyrosine Hydroxylase Activity

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Neuroendocrine findings in the schizophrenias.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Negative symptoms of schizophrenia and the dexamethasone suppression test

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Influence of the menstrual cycle phase on the therapeutic response in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender differences in the course of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender and the expression of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Sex steroid hormones change the differential distribution of the isoforms of the D2 dopamine receptor messenger RNA in the rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Schizophrenia throughout life: sex differences in severity and profile of symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Variation in symptom severity over the menstrual cycle of schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Evidence for a gender bias in epidemiological studies of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Late-onset schizophrenia: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Decreased hippocampal expression of a glutamate receptor gene in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The effect of methylphenidate on serum growth hormone: influence of antipsychotic drugs and diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Negative and depressive symptoms in suicidal schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Blunted acth response to hypoglycemic stress in depressed patients but not in patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Epidemiology of puerperal psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Lack of Arginine Vasopressin Response to Central Dopamine Blockade in Normal Adults*

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Endocrine responses to tryptophan infusion in schizophrenic patients treated with neuroleptics.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

A clinical trial of the effects of estrogen in acutely psychotic women

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Neuroendocrine responses in chronic schizophrenia. Evidence for serotonergic dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17 beta-estradiol

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Neurochemistry and neuroendocrinology of schizophrenia: a selective review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia. Prevalence and clinical correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Time course and biologic correlates of treatment response in first-episode schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Qualitative assessment of brain morphology in acute and chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Cerebrospinal fluid neurophysins in affective illness and in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Excitatory amino acids as a final common pathway for neurologic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Sex difference in age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Acute psychiatric admission related to the menstrual cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca2+ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effect of clonidine on growth hormone release in psychiatric patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Methodological aspects of onset assessment in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone response to growth hormone-releasing hormone in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

A prospective study of postpartum psychoses in a high-risk group. 1. Clinical characteristics of the current postpartum episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Interactions of estrogen with the neurotrophins and their receptors during neural development.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Multihormonal responses to apomorphine in mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: neuroendocrine evidence for a GABA disturbance in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Seasonal variation in the dexamethasone suppression test: a longitudinal study in chronic schizophrenics and in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Excitatory effect of dopamine on oxytocin and vasopressin reflex releases in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prolactin responses to domperidone in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Influence of sex steroids and prolactin on haloperidol-induced catalepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effect of metoclopramide in plasma vasopressin in man

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Sex differences in brain morphology in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Serum gonadal steroid hormones in young schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone responses to pyridostigmine in schizophrenia: Evidence for cholinergic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Postsynaptic supersensitivity in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Monoamine oxidase and cortisol response in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prolactin bioassay in schizophrenia before and after neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone response to growth hormone releasing hormone in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Five-year outcome and prognosis in schizophrenia: a report from the London Field Research Centre of the International Pilot Study of Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Membrane sex-steroid receptors in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Schizophrenia--a disease of young single males? Preliminary results from an investigation on a representative cohort admitted to hospital for the first time

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Further evidence for a specific role of estradiol in schizophrenia?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Schizophrenia and oestrogens--is there an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Can estradiol modulate schizophrenic symptomatology?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

A review of disorders of water homeostasis in psychiatric patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Characterization of a growth hormone-releasing factor from a human pancreatic islet tumour.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: a gender effect

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prolactin plasma levels and D2-dopamine receptor occupancy measured with IBZM-SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Development and regeneration of the nervous system: a role for neurosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Psychopathology in women and men: focus on female hormones

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Current outcome in schizophrenia: women vs men

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Pharmacological effects of methylphenidate on plasma homovanillic acid and growth hormone

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender differences in the clinical expression of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Alterations in phencyclidine and sigma binding sites in schizophrenic brains. Effects of disease process and neuroleptic medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Estrogen protects primary cortical neurons from glutamate toxicity.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone response to TRH in families multiply affected with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

A review of GHRH stimulation test in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Relationship between DST nonsuppression and shortened REM latency in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Gender differences in schizophrenia. Results of a follow-up study from India

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro: III. Effects of estrogen on dendritic differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Animal models for the study of anti-anxiety agents: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Inhibition of dopamine of oxytocin release from isolated posterior lobe of the hypophysis of the rat; disinhibitory effect of beta-endorphin/enkephalin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Thyrotropin response to thyrotropin-releasing hormone in RDC schizodepressed men

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Prolactin response to thyrotropin-releasing hormone in schizoaffective depressed compared to depressed and schizophrenic men and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Growth hormone neuroregulation and the clinical relevance of somatostatin

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Estrogen stakes claim to cognition.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

Premorbid Social Competence and Outcome among Schizophrenic and Nonschizophrenic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2805%2970013-7

7 January 2021

10.1016/S0193-953X(05)70013-7

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9670234

1 reference

5 February 2018